Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block
for
Pain
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 21 - 70+
Code: NCT07174440
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for
Prostate Cancer Metastatic
Location: Cleveland OH, Toronto, Charlottesville VA, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136624
Phase3, Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Get alerts for new trials in your area by subscribing now
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
for
Acute Myeloid Leukemia (AML)
Location: Canton OH, Cincinnati, OH, Fairway KS, Dallas TX,
Sponsor: Aptevo Therapeutics
Sex: All
Age: 18+
Code: NCT06634394
Phase1, Recruiting
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
for
Tardive Dyskinesia, Intellectual Disability,
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06997198
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
for
HER2-positive Advanced Solid Tumor
Location: Canton OH, Pittsburgh PA, Fairfax VA, Silver Spring MD,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05150691
Phase1, Phase2, Recruiting
Rectus Abdominis Detrusor Myoplasty for Urinary Retention
for
Urinary Retention, Urinary Retention After Procedure,
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 18 - 70+
Code: NCT07379814
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
for
Urinary Tract Infections
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 18+
Code: NCT06808451
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Cleveland OH, Detroit MI, Farmington Hills MI,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase2, Recruiting
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
for
Stress Urinary Incontinence, Vaginal Prolapse
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: Female
Age: 18+
Code: NCT06754046
Recruiting
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Canton OH, Port Huron MI, Bloomington IN,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.
for
Persistent Spinal Pain Syndrome
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 30+
Code: NCT07091123
Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Cleveland OH, Grand Rapids MI, Fairfax VA,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase1, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Cleveland OH, Detroit MI, Mississauga, Toronto,